News
This Series C comes less than a year after the startup closed its $200 million Series B in 2020.
CEO Mark Zuckerberg also announced that the company will be using WhatsApp's chatbots to help with vaccine registration.
Funding will be used to push for regulatory approval of its flagship synthetic implant product.
The analyser is part of an assessment of the AI-based ‘CURIAL’ test to screen for COVID-19 in patients.
The company also revealed new partnerships with AdvancedMd, DrChrono and athenahealth.
The company boasted strong revenues and membership growth but took a hit in its GAAP net income.
Also, mental health website for new mums launches.
Today at Cleveland Clinic and HIMSS' Patient Experience Summit, Dr. David Newhouse, formerly of Permanente Medical Group, discussed putting statistics into practice.
The acquisition allows cliexa to meet GI customers with an end-to-end automated scheduling, reporting and communications platform.
While these features are built to be used by all working families on the Cleo platform, it’s those families who do face discrimination who will benefit the most.